Are you on the hunt for some investment ideas?
If you are, then you may want to check out the ASX shares listed below that the team at Morgans thinks investors should accumulate.
Here's what the broker is saying about these names:
Image source: Getty Images
CAR Group Limited (ASX: CAR)
This auto listings company impressed the broker with its FY 2025 results. So much so, the broke responded by putting an accumulate rating and $40.80 price target on its shares.
It highlights that management is expecting double digit earnings growth in FY 2026. It said:
Whilst CAR's FY25 was strong overall in our view, there was little surprise in the headline numbers given they were largely pre-released via relatively tight guidance ranges last month. CAR reported double-digit topline and EBITDA growth for FY25, with FY26 guidance implying 10-13% Proforma EBITDA growth and ongoing investment across key offshore markets (North American and Asia). We lower FY26/FY27F EBITDA by ~1% on newly provided quantitative guidance by management. Our DCF-derived price target remains unchanged at A$40.80 and we maintain our ACCUMULATE recommendation.
Iress Ltd (ASX: IRE)
Morgans was relatively pleased with this financial technology company's full year results. As a result, it put an accumulate rating and $9.69 price target on its shares.
Though, it sees potential for an even higher valuation under a takeover scenario. It explains:
IRE reported adjusted EBITDA of A$64.4m, in-line with expectations. Continuing Ops EBITDA (A$60.2m) was +8.7% on pcp and flat half-on-half. The result absorbed investment costs of A$5.8m (~10% growth excluding investment). Weaker cash flow (one-offs); larger one-off costs and the departure of the Deputy CEO were negatives. However the outlook was in-line (minor forecast changes). FY25 Adjusted EBITDA guidance was maintained at A$127-135m. Implied 2H25 adjusted EBITDA (A$62.6-70.6m) is ~4-17% continuing ops growth hoh.
Medium-term targets were outlined, pointing to ~7% growth during investment phase. IRE is set up for reasonable growth during an extra investment phase (FY26/27). We consider the 'live' corporate appeal as providing some extra risk/reward to the investment case. We have an ACCUMULATE rating based on our fundamental valuation. Under a takeover scenario we see >A$10.50ps more appropriate.
LGI Ltd (ASX: LGI)
Finally, Morgans has put an accumulate rating and $4.20 price target on this ASX share following its results release.
It notes that this clean energy company delivered on its guidance in FY 2025. However, the main positive was a new battery contract win, which bodes well for its future performance. It said:
LGI hit the mid-point of FY25 guidance, delivering 13.6% EBITDA growth on FY24. The underlying result was in line with expectations, but the highlight was a new battery contract win (12MW) – bringing total new contract wins to six for FY25 and increasing the medium term development pipeline to ~56MW (from 47MW). We continue to like the long-term and structural growth opportunity ahead of LGI as it works through its multi-year capex program. We expect a structural uplift in FY26F EPS (+29%) as LGI realises its FY25 investments. Strong operational execution and contract wins support the positive outlook. Maintain Accumulate.
